PolgarG, WengTR. The functional development of the respiratory system from the period of gestation to adulthood. Am Rev Respir Dis1979;120:625–695.
2.
ThurlbeckWM. Postnatal growth and development of the lung. Am Rev Respir Dis1975;111:803–844.
3.
DunnillMS. The problem of lung growth (editorial). Thorax1982;37:561–563.
4.
ThurlbeckWM, AngusGE. Growth and aging of the normal human lung. Chest1975;67(2, Suppl):3S–7S.
5.
DunnillMS. Postnatal growth of the lung. Thorax1962;17:329–333.
6.
LangstonC, KidaK, ReedM, ThurlbeckWM. Human lung growth in late gestation and in the neonate. Am Rev Respir Dis1984;129:607–613.
7.
HoggJC, WilliamsJ, RichardsonJB, MacklemPT, ThurlbeckWM. Age as a factor in the distribution of lower-airway conductance and in the pathologic anatomy of obstructive lung disease. N Engl J Med1970; 282:1283–1287.
8.
MacklinCC. Alveolar pores and their significance in the human lung. Arch Pathol1936;21:202–216.
9.
MatsubaK, ThurlbeckWM. A morphometric study of bronchial and bronchiolar walls in children. Am Rev Respir Dis1972;105:908–913.
10.
LenneyW, MilnerAD. At what age do bronchodilator drugs work? Arch Dis Child1978;53:532–535.
11.
TepperRS. Airway reactivity in infants: A positive response to methacholine and metaproterenol. J Appl Physiol1987;62:1155–1159.
12.
MotoyamaEK, FortMD, KleshKW, MutichRL, GuthrieRD. Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia. Am Rev Respir Dis1987;136:50–57.
13.
PrendivilleA, MaxwellDL, RoseA, SilvermanM.Histamine-induced airway obstruction in infancy: Changes in oxygenation. Pediatr Pulmonol1988;4:164–168.
14.
LesouefPN, GeelhoedGC, TurnerDJ, MorganSEG, LandauLI. Response of normal infants to inhaled histamine. Am Rev Respir Dis1989;139:62–66.
15.
GellerDE, MonanWJ, CotaKA, WrightAL, TaussigLM. Airway reponsiveness to cold, dry air in normal infants. Pediatr Pulmonol1988;4:90–97.
16.
StarkAR, FrantzID. Respiratory distress syndrome. Pediatr Clin North Am1986;33:533–544.
17.
PolakMJ, PolakJD, BucciarelliRL. Perspectives on respiratory distress syndrome of the newborn. Compre-hensive Therapy1989;15:28–34.
18.
SchreinerRL, BradburnNC. Newborns with acute respiratory distress: Diagnosis and management. Pediatr Rev1988;9:279–285.
19.
LindrothM.Current perspectives in the management of respiratory distress syndrome. Ind Pediatr1988;25:654–665.
20.
Dal NogareAR. Southwestern internal medicine conference: Adult respiratory distress syndrome. Am J Med Sci1989;298:413–430.
BalkR, BoneRC. The adult respiratory distress syndrome. Med Clin North Am1983;67:685–700.
23.
ShaleDJ. The adult respiratory distress syndrome: Twenty years on (editorial). Thorax1987;42:641–645.
24.
BreslerMJ, SternbachGL. The adult respiratory distress syndrome. Emerg Med Clin North Am1989;7:419–430.
25.
WardPA, JohnsonKJ, TillGO. Current concepts regarding adult respiratory distress syndrome. Ann Emerg Med1985;14:724–728.
26.
MatthayMA. The adult respiratory distress syndrome: New insights into diagnosis, pathophysiology, and treatment. West J Med1989;150:187–194.
27.
NorwoodSH, CivettaJM. The adult respiratory syndrome. Surg Gynecol Obstet1985;161:497–508.
28.
WeigeltJA. Current concepts in the management of the adult respiratory distress syndrome. World J Surg1987;11:161–166.
29.
RoyallJA, LevinDL. Adult respiratory distress syndrome in pediatric patients: Clinical aspects, pathophysiology, pathology, and mechanisms of lung injury. J Pediatr1988;112:169–180.
30.
NussbaumE.Adult-type respiratory distress syndrome in children. Clin Pediatr1983;22:401–406.
31.
LyreneRK, TruogWE. Adult respiratory distress syndrome in a pediatric intensive care unit: Predisposing conditions, clinical course, and outcome. Pediatrics1981;67:790–795.
DownsJB, OlsenGN. Pulmonary function following adult respiratory distress syndrome. Chest1974;65:92–93.
34.
ElliottCG, MorrisAH, GenqizM.Pulmonary function and exercise gas exchange in survivors of adult respiratory distress syndrome. Am Rev Respir Dis1981;123:492–499.
35.
LakshminarayanS, HudsonLD. Pulmonary function following adult respiratory distress syndrome (editorial). Chest1978;74:489–490.
36.
SimpsonDL, GoodmanM, SpectorSL, PettyTL. Long-term follow-up and bronchial reactivity testing in survivors of the adult respiratory distress syndrome. Am Rev Respir Dis1978;117:449–454.
37.
YahavJ, LiebermanP, MolhoM.Pulmonary function following the adult respiratory distress syndrome. Chest1978;74:247–250.
38.
FanconiS, KraemerR, WeberJ, TschaeppelerH, PfenningerJ.Long-term sequelae in children surviving adult respiratory distress syndrome. J Pediatr1985;106:218–222.
39.
NorthwayWH, RosanRC, PorterDY. Pulmonary disease following respirator therapy of hyaline-membrane disease. N Engl J Med1967;276:357–368.
40.
O'BrodovichHM, MellinsRB. Bronchopulmonary dysplasia. Am Rev Respir Dis1985;132:694–709.
PhilipAGS. Oxygen plus pressure plus time: The etiology of bronchopulmonary dysplasia. Pediatrics1975;55:44–50.
50.
TooleyWH. Epidemiology of bronchopulmonary dysplasia. J Pediatr1979;95:851–855.
51.
SauveRS, SinghalN.Long-term morbidity of infants with bronchopulmonary dysplasia. Pediatrics1985;76:725–733.
52.
SaigalS, O'BrodovichH.Long-term outcome of preterm infants with respiratory disease. Clin Perinat1987;14:635–650.
53.
CoatesAL, BergsteinssonH, DesmondK, OuterbridgeEW, BeaudryPH. Long-term pulmonary sequelae of premature birth with and without idiopathic respiratory distress syndrome. J Pediatr1977;90:611–616.
54.
HeldtGP, McIlroyMB, HansenTN, TooleyWH. Exercise performance of the survivors of hyaline-membrane disease. J Pediatr1980;96:995–999.
55.
SmythJ, TabachnikE, DuncanWJ, ReillyBJ, LevisonH.Pulmonary function and bronchial hyperreactivity in long-term survivors of bronchopulmonary dysplasia. Pediatrics1981;68:336–340.
56.
HodsonME. Cystic fibrosis. Postgrad Med J1984;60:225–233.
57.
WheelerWB, ColtenHR. Cystic fibrosis: Current approach to diagnosis and management. Pediatr Rev1988;9:241–248.
58.
KuhnRJ, NahataMC. Therapeutic management of cystic fibrosis. Clin Pharm1985;4:555–565.
59.
SternRC. Cystic fibrosis: Recent developments in diagnosis. Pediatr Rev1986;7:276–286.
60.
BlytheSA, FarrellPM. Advances in the diagnosis and management of cystic fibrosis. Clin Biochem1984;17:277–283.
61.
DavisPB, di Sant'AgnesePA. Diagnosis and treatment of cistic fibrosis. Chest1984;85:802–809.
62.
FickRB, StillwellPC. Controversies in management of pulmonary disease due to cystic fibrosis. Chest1989;95:1319–1327.
63.
NelsonJD. Management of acute pulmonary exacer-bations in cystic fibrosis: A critical appraisal. J Pediatr1985;106:1030–1034.
CollinsFF, RiordanJR, TsuiLC. The cystic fibrosis gene: Isolation and significance. Hosp Pract1990;25:47–57.
69.
KeremB, RommensJM, BuchananJA, . Identi-fication of the cystic fibrosis gene: Genetic analysis. Science1989;245:1073–1080.
70.
MatthewsLW, DrotarD.Cystic fibrosis: A challenging long-term chronic disease. Pediatr Clin North Am1984;31:133–152.
71.
MurphyS.Cystic fibrosis in adults: Diagnosis and management. Clin Chest Med1987;8:695–710.
72.
HodsonM.Managing adults with cystic fibrosis. Br Med J1989;298:171–172.
73.
WebbAK. The difficulties of treating cystic fibrosis in adults. J Royal Soc Med1987;80:47–50.
74.
ShepherdSL, HovellMF, HarwoodI, . A comparative study of the psychosocial assets of adults with cystic fibrosis and their healthy peers. Chest1990;97:1310–1316.
75.
LewistonN.The CF "young adult comes of age. Chest1990;97:1282–1283.
76.
HuangNN, SchidlowDV, SzatrowskiTH, . Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis. Am J Med1987;82:871–879.
77.
SweezeyNB, FellowsKE. Bronchial artery embolization for severe hemoptysis in cystic fibrosis. Chest1990;97:1322–1326.
78.
FitzpatrickSB, StokesDC, RosensteinBJ, TerryP, HubbardVS. Use of oral contraceptives in women with cystic fibrosis. Chest1984;86:863–867.
79.
SimpsonDL, GoodmanM, SpectorSL, PettyTL. Long-term follow-up and bronchial reactivity testing in survivors of the adult respiratory distress syndrome. Am Rev Respir Dis1978;117:449–454.
80.
ZeigerRS. Special considerations in the approach to asthma in infancy and early childhood. J Asthma1983; 20:341–359.
81.
KonigP.Asthma: A pediatric pulmonary disease and a changing concept. Pediatr Pulmonol1987;3:264–275.
82.
LenfantC, HurtSS. National asthma education program. Chest1990;98:226–227.
CroppGJ. Special features of asthma in children. Chest1985;87(1, Suppl):55S–62S.
85.
HenJHJr. An overview of pediatric asthma. Pediatr Ann1986;15:92–96.
86.
SeigelSC, RachelefskyGS. Asthma in infants and children: Part 1. J Allergy Clin Immunol1985;76:1–15.
87.
NelsonDR, SachsMI, O'ConnellEJ. Approaches to acute asthma and status asthmaticus in children. Mayo Clin Proc1989;64:1392–1402.
88.
EllisEF. Asthma in childhood. J Allergy Clin Immunol1983;72:526–539.
89.
SearsMR. Are deaths from asthma really on the rise? J Respir Dis1987;8(8):39–49.
90.
MakH, JohnstonP, AbbeyH, TalamoRC. Prevalence of asthma and health service utilization of asthmatic children in an inner city. J Allergy Clin Immunol1982;70:367–372.
91.
McDonaldAJ. Asthma. Emerg Med Clin North Am1989;7:219–235.
92.
GerritsenJ, KoeterGH, PostmaDS, SchoutenPR, KnolK.Prognosis of asthma from childhood to adulthood. Am Rev Respir Dis1989;140:1325–1330.
93.
SingerL, DrotarD, DoershukC.Psychosocial management of chronic lung disorders. Pediatrician1988;15:29–36.
94.
ConnersCK. Psychological management of the asthmatic child: A review. Clin Rev Allerg1983;1:163–177.
95.
Blessing-MooreJ, FritzG, LewistonNJ. Self-management programs for childhood asthma. Chest1985;87(1, Suppl):107S–110S.
96.
GoldhagenJL. Croup: Pathogenesis and management. J Emerg Med1983;1:3–11.
97.
BaughR, GilmoreBBJr. Infectious croup: A critical review. Otolaryngol Head Neck Surg1986;95:40–46.
98.
CourielJM. Management of croup. Arch Dis Child1988;63:1305–1308.
99.
SkolnikNS. Treatment of croup. AJDC1989;143:1045–1049.
100.
DiazJH. Croup and epiglottitis in children: The anesthesiologist as diagnostician. Anesth Analg1985;64:621–633.
101.
TrollforsB, NylkenO, StangertK.Acute epiglottitis in children and adults in Sweden 1981-3. Arch Dis Child1990;65:491–494.
BishopMJ. Epiglottitis in the adult. Anesthesiology1981;55:701–702.
107.
SarantG.Acute epiglottitis in adults. Ann Emerg Med1981;10:58–61.
108.
ChaissonRE, RossJ, GerberdingJL, SandeMA. Clinical aspects of adult epiglottitis. Western J Med1986;144:700–703.
109.
CohenEL. Epiglottitis in adults. Ann Emerg Med1984;13:620–623.
110.
MayoSmithMF, HirschPJ, WodzinskiSF, SchiffmanFJ. Acute epiglottitis in adults: An eight year experience in the state of Rhode Island. N Engl J Med1986; 314:1133–1139.
111.
KhilananiU, KhatibR.Acute epiglottitis in adults. Am J Med Sci1984;287:65–70.
112.
BakerAS, EaveyRD. Adult supraglottitis (epiglottitis). N Engl J Med1986;314:1185–1186.
CannyGJ, LevisonH.Aerosols: Therapeutic use and delivery in childhood asthma. Ann Allerg1988;60:11–19.
115.
SinghM, KumarL.Aerosol treatment of asthma. Indian J Pediatr1988;25:361–367.
116.
RachelefskyGS, SiegelSC. Asthma in infants and children Treatment of childhood asthma: Part II. J Allerg Clin Immunol1985;76:409–425.
117.
PedersonS.Inhaler use in children with asthma. Danish Med Bulletin1987;34:234–249.
118.
LevisonH, ReilleyPA, WorsleyGH. Spacing devices and metered-dose inhalers in childhood asthma. J Pediatr1985;107:662–668.
119.
RivlinJ, MindorffC, LevisonH, KazimF, ReilleyP, WorsleyG.Effect of administration technique on bronchodilator response to fenoterol in a metered-dose inhaler. J Pediatr1983;102:470–472.
120.
BaciewiczAM, KyllonenKS. Aerosol inhaler technique in children with asthma. Am J Hosp Pharm1989; 46:2510–2511.
121.
BrudnoDS, ParkerDH, SlatonG.Response of pulmonary mechanics to terbutaline in patients with bronchopulmonary dysplasia. Am J Med Sci1989; 297:166–168.
122.
ConnerWT, DolovichMB, FrameRA, NewhouseMT. Reliable salbutamol administration in 6- to 36-month-old children by means of a metered dose inhaler and aerochamber with mask. Pediatr Pulmonol1989;6:263–267.
123.
MallolJ, BarruetoL, GirardiG, ToroO.Bronchodilator effect of fenoterol and ipratropium bromide in infants with acute wheezing: Use of MDI with a spacer device. Pediatr Pulmonol1987;3:352–356.
124.
SlyRM, BarberaJM, MiddletonHB, EbyDM. Delivery of albuterol aerosol by aerochamber to young children. Ann Allergy1988;60:403–406.
125.
RachelefskyGS, RohrAS, WoJ, . Use of a tube spacer to improve the efficacy of a metered-dose inhaler in asthmatic children. AJDC1986;140:1191–1193.
126.
GurwitzD, LevisonJ, MindorffC, RoillyP, WorsleyG.Assessment of a new device (Aerochamber) for use with aerosol drugs in asthmatic children. Ann Allergy1983;50:166–170.
127.
LewDB, HerrodHG, CrawfordLV. Combination of atropine and isoetharine aerosol therapy in pediatric acute asthma. Ann Allerg1990;64:195–200.
128.
ShapiroGG, FurukawaCT, PiersonWE, SharpeMJ, MenendezR, BiermanCW. Double-blind evaluation of nebulized cromolyn, terbutaline, and the combination for childhood asthma. J Allerg Clin Immunol1988; 81:449–454.
129.
WatsonWTA, BeckerAB, SimonsFER. Comparison of ipratropium solution, fenoterol solution, and their combination administered by nebulizer and face mask to children with acute asthma. J Allerg Clin Immunol1988;82:1012–1018.
130.
BlackhallMI, O'DonnellSR. A dose-response study of inhaled terbutaline administered via Nebuhaler or nebulizer to asthmatic children. Eur J Respir Dis1987;71:96–101.
131.
RitchieD, ErbenA, McLennanL, LandauLI, PhelanPD. Dose of terbutaline respirator solution in children with asthma. NZ Med J1979;89:332–334.
FreemanJ, LandauLI. The effects of ipratropium bromide and fenoterol nebulizer solutions in children with asthma. Clin Pediatr1989;28:556–560.
134.
PostDJ. Inhaled bronchodilator use in infants: A national survey (abstract). Respir Care1989;34:1024.
135.
RobertsonCF, SmithF, BeckR, LevisonH.Response to frequent low doses of nebulized salbutamol in acute asthma. J Pediatr1985;106:672–674.
136.
SchuhS, ParkinP, RajanA, . High- versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma. Pediatrics1989;83:513–518.
137.
ReismanJ, Galdes-SebaltM, KazimF, CannyG, LevisonH.Frequent administration by inhalation of salbutamol and ipratropium bromide in the initial management of severe acute asthma in children. J Allerg Clin Immunol1988;81:16–20.
138.
MolerFW, HurwitzME, CusterJR. Improvement in clinical asthma score and PaCO₂ in children with severe asthma treated with continuously nebulized terbutaline. J Allerg Clin Immunol1988;81:1101–1109.
139.
PortnoyJ, AggarwalJ.Continuous terbutaline nebulization for the treatment of severe exacerbations of asthma in children. Ann Allerg1988;60:368–371.
140.
ZimoDA, GasparM, AkhterJ.The efficacy and safety of home nebulizer therapy for children with asthma. AJDC1989;143:208–211.
141.
RyanCA, WillanAR, WherrettBA. Home nebulizers in childhood asthma. Clin Pediatr1988;27:420–424.
142.
IsaacsD.Ribavirin. Pediatrics1987;79:289–291.
143.
EgglestonM.Clinical review of ribavirin. Infection Control1987;8:215–218.
144.
Van Steensel-MollHA, Van der VoortE, BosAP, RothbarthPH, NeijensHJ. Respiratory syncytial virus infections in children admitted to the intensive care unit. Pediatrics1989;44:583–588.
145.
ByronPR, PhillipsEM, KuhnR.Ribavirin adminis-tration by inhalation: Aerosol-generation factors controlling drug delivery to the lung. Respir Care1988;33:1011–1019.
146.
NewthCJ, ClarkAR. In vitro performance of the small particle aerosol generator (SPAG-2). Pediatr Pulmonol1989;7:183–188.
147.
DemersRR, ParkerJ, FrankelLR, SmithDW. Administration of ribavirin to neonatal and pediatric patients during mechanical ventilation. Respir Care1986;31:1188–1196.
148.
LissHP, BernsteinJ.Ribavirin aerosol in the elderly. Chest1988;93:1239–1241.
149.
RodriguezWJ, Dang BuiRH, ConnerJD, . Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections. Antimicrob Agents Chemother1987;31:1143–1146.
150.
GappaM, SteinkampG, TummlerB, von der HardtH.Long-term tobramycin aerosol therapy of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis. Scand J Gastroenterol1988;23:74–76.
IlowiteJS, GorvoyJD, SmaldoneGC. Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am Rev Respir Dis1987;136:1445–1449.
153.
SmithAL, RamseyBW, HedgesDL, . Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis. Pediatr Pulmonol1989; 7:265–271.
154.
AppEM, KingM, HelfesriederR, KohlerD, MatthysH.Acute and long-term amiloride inhalation in cystic fibrosis lung disease: A rational approach to cystic fibrosis therapy. Am Rev Respir Dis1990;141:605–612.
155.
KnowlesMR, ChurchNL, WaltnerWE, . A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N Engl J Med1990;322:1189–1194.
156.
DesmondKJ, SchwenkWF, ThomasE, BeaudryPH, CoatesAL. Immediate and long-term effects of chest physiotherapy in patients with cystic fibrosis. J Pediatr1983;103:538–542.
157.
RossmanCM, WaldesR, SampsonD, NewhouseMT. Effect of chest physiotherapy on the removal of mucus in patients with cystic fibrosis. Am Rev Respir Dis1982;126:131–135.
158.
FinerNN, BoydJ.Chest physiotherapy in the neonate: A controlled study. Pediatrics1978;2:285.
159.
EtchesPC, ScottB.Chest physiotherapy in the newborn: Effect on secretions removed. Pediatrics1978;62:713–715.
160.
FinerNN, MoriarteyRR, BoydJ, PhillipsHJ, StewartAR, UlanO.Postextubation atelectasis: A retrospective review and a prospective controlled study. J Pediatr1979;94:110–113.
161.
FalkM, KelstrupM, AndersonJB, . Improving the ketchup bottle method with positive expiratory pressure, PEP, in cystic fibrosis. Eur J Respir Dis1984;65:423–432.
162.
OberwaldnerB, EvansJC, ZachMS. Forced expirations against a variable resistance: A new chest physiotherapy method in cystic fibrosis. Pediatr Pulmonol1986;2:358–367.
163.
TonnesenP, StovringS.Positive expiratory pressure (PEP) as lung physiotherapy in cystic fibrosis: A pilot study. Eur J Respir Dis1984;65:419–422.
HofmeyrJL, WebberBA, HodsonME. Evaluation of positive expiratory pressure as an adjunct to chest physiotherapy in the treatment of cystic fibrosis. Thorax1986;41:951–954.
166.
GrothS, StafangerG, DirksenH, AndersonJB, FalkM, KelstrupM.Positive expiratory pressure (PEP-mask) physiotherapy improves ventilation and reduces volume of trapped gas in cystic fibrosis. Bull Eur Physiopathol Respir1985;21:339–343.
167.
HessD.The use of PEEP in clinical settings other than acute lung injury. Respir Care1988;33:581–597.
168.
SchoniMH. Autogenic drainage: A modern approach to physiotherapy in cystic fibrosis. J Royal Soc Med1989;82:32–37.
169.
PryorJA, WebberBA, HodsonME, BattenJC. Evaluation of the forced expiration technique as an adjunct to postural drainage in treatment of cystic fibrosis. Br Med J1979;2:417–418.
170.
RubinEM, ScantlenGE, ChapmanGA, EldridgeM, MenendezR, WannerA.Effect of chest wall oscillation on mucus clearance: Comparison of two vibrators. Pediatr Pulmonol1989;6:122–126.
171.
PaviaD, ThomsonML, PhillipakosD.A preliminary study of the effect of a vibrating pad on bronchial clearance. Am Rev Respir Dis1976;113:92–96.
172.
KingM, PhillipsDM, GrossD, VartianV, ChangHK, ZidulkaA.Enhanced tracheal mucus clearance with high frequency chest wall compression. Am Rev Respir Dis1983;128:511–515.
173.
KingM, PhillipsDM, ZidulkaA, ChangHK. Tracheal mucus clearance in high frequency oscillation. II. Chest wall versus mouth oscillation. Am Rev Respir Dis1984;130:703–706.
174.
GeorgeRJD, JohnsonMA, PaviaD, AgnewJE, ClarkeSW, GeddesDM. Increase in mucociliary clearance in normal man induced by oral high frequency oscillation. Thorax1985;40:433–437.
175.
GregoryGA, KittermanJA, PhibbsRH, TooleyWH, HamiltonWK. Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. N Engl J Med1971;284:1333–1340.
176.
AveryME, TooleyWH, KellerJB, . Is chronic lung disease in low birth weight infants preventable? Pediatrics1987;79:26–30.
177.
HorbarJD, McAuliffeTL, AdlerSM, . Variability in 28-day outcomes for very low birth weight infants: An analysis of 11 neonatal intensive care units. Pediatrics1988;82:554–559.
178.
KraybillEN, RunyanDK, BoseCL, KhanJH. Risk factors for chronic lung disease in infants with birth weights of 751 to 1000 grams. J Pediatr1989;115:115–120.
179.
RhodesPG, GravesGR, PatelDM, CampbellSB, BlumenthalBI. Minimizing pneumothorax and broncho-pulmonary dysplasia in ventilated infants with hyaline-membrane disease. J Pediatr1983;103:634–637.
180.
BransonRD. PEEP without endotracheal intubation. Respir Care1988;33:598–612.
SandersMH, KernN.Obstructive sleep apnea treated by independently adjusted inspiratory and expiratory positive airway pressures via nasal mask. Physiologic and clinical implications. Chest1990;98:317–324.
183.
StrumpfDA, CarlisleCC, MillmanRP, SmithKW, HillNS. An evaluation of the Respironics BiPAP bi-level CPAP device for delivery of assisted ventilation. Respir Care1990;35:415–422.
184.
PinillaJC, OleniukFH, TanL, . Use of a nasal continuous positive airway pressure mask in the treatment of postoperative atelectasis in aortocoronary bypass surgery. Crit Care Med1990;18:836–840.
185.
CarrollN, BranthwaiteMA. Control of nocturnal hypoventilation by nasal intermittent positive pressure ventilation. Thorax1988;43:349–353.
186.
GuilleminaultC, StoohsR, SchneiderH, PodszusT, PeterJH, von WichertP.Central alveolar hypoventilation and sleep. Chest1989;96:1210–1212.
187.
BachJR, AlbaA, MosherR, DelaubierA.Intermittent positive pressure ventilation via nasal access in the management of respiratory insufficiency. Chest1987; 92:168–170.
188.
EllisER, ByePT, BrudererJW, SullivanCE. Treatment of respiratory failure during sleep in patients with neuromuscular disease. Positive pressure through a nose mask. Am Rev Respir Dis1987;135:148–152.
189.
DiMarcoAF, ConnersAF, AltoseMD. Management of chronic alveolar hypoventilation with nasal positive pressure breathing. Chest1987;92:952–954.
190.
ReynoldsEOR, TaghizadehA.Improved prognosis of infants mechanically ventilated for hyaline-membrane disease. Arch Dis Child1974;49:505–515.
HermanS, ReynoldsEOR. Methods for improving oxygenation in infants mechanically ventilated for severe hyaline-membrane disease. Arch Dis Child1973;48:612–617.
193.
ReynoldsEOR. Effect of alterations in mechanical ventilator settings on pulmonary gas exchange in hyaline-membrane disease. Arch Dis Child1971;46:152–159.
194.
BorosSJ, MatalonSV, EwaldR, LeonardAS, HuntCE. The effect of independent variations in inspiratory-expiratory ratio and end expiratory pressure during mechanical ventilation in hyaline-membrane disease: The significance of mean airway pressure. J Pediatr1977;91:794–798.
195.
BorosSJ. Variations in inspiratory:expiratory ratio and airway pressure wave form during mechanical venti-lation: The significance of mean airway pressure. J Pediatr1979;94:114–117.
196.
GurevitchMJ, Van DykeJ, YoungES, JacksonK.Improved oxygenation and lower peak airway pressure in severe adult respiratory distress syndrome. Chest1986;89:211–213.
197.
TharrattRS, AllenRP, AlbertsonTE. Pressure controlled inverse ratio ventilation in severe adult respiratory failure. Chest1988;94:755–762.
198.
LainDC, DiBenedettoR, MorrisSL, Van NguyenA, SaultersR, CauseyD.Pressure control inverse ratio ventilation as a method to reduce peak inspiratory pressure and provide adequate ventilation and oxyge-nation. Chest1989;95:1081–1088.
199.
AbrahamE, YoshiharaG.Cardiorespiratory effects of pressure controlled inverse ratio ventilation in severe respiratory failure. Chest1989;96:1356–1359.
200.
DuncanSR, RizkNW, RaffinTA. Inverse ratio ventilation: PEEP in disguise? (editorial) Chest1987;92:390–391.
201.
MatthayMA. New modes of mechanical ventilation for ARDS: How should they be evaluated? (editorial). Chest1989;95:1175–1177.
202.
KacmarekRM, HessD.Pressure-controlled inverse ratio ventilation: Panacea or auto-PEEP? (editorial). Respir Care1990;35:945–948.
203.
WetzelRC, GioiaFR. Classification of high frequency ventilation. Pediatr Clin North Am1987;34:15–38.
204.
CarlonGC, CombsAH, GroegerJS. Ventilation at supraphysiologic frequencies. Acute Care1983-1984;10:123–183.
SchusterDP, KlainM, SnyderJ.Comparison of high frequency jet ventilation to conventional mechanical ventilation during severe acute respiratory failure in humans. Crit Care Med1982;10:625–630.
210.
HolzapelL, PerrinRF, GaussorguesP, GuidicelliDP. Comparison of high-frequency jet ventilation to conventional ventilation in adults with respiratory distress syndrome. Intensive Care Med1987;13:100–105.
211.
CarloWA, ChatburnRL, MartinRJ, . Decrease in airway pressure during high-frequency jet ventilation in infants with respiratory distress syndrome. J Pediatr1984;104:101–107.
212.
CarloWA, ChatburnRL, MartinRJ. Randomized trial of high frequency jet ventilation versus conventional ventilation in respiratory distress syndrome. J Pediatr1987;110:275–282.
213.
HIFI Study Group. High-frequency oscillatory ventila-tion compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. N Engl J Med1989;320:88–93.
214.
HIFI Study Group. High-frequency oscillatory ventila-tion compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants: Assessment of pulmonary function at 9 months of corrected age. J Pediatr1990;116:933–941.
215.
EmricoJ.Transcutaneous oxygen monitoring in neonates. Respir Care1979;24:601–605.
216.
RoothG, HuchA, HuchR.Transcutaneous oxygen monitors are reliable indicators of arterial oxygen tension (if used correctly). Pediatrics1987;79:283–286.
217.
MartinRJ. Transcutaneous monitoring: Instrumentation and clinical application. Respir Care1990;35:577–583.
218.
McEvedyBAB, McLeodME, MuleraM, KirpalaniH, LermanJ.End-tidal, transcutaneous, and arterial pCO₂ measurements in critically ill neonates: A comparative study. Anesthesiology1988;69:112–116.
219.
FanconiS, DohertyP, EdmondsJF, BarkerGA, BohnDJ. Pulse oximetry in pediatric intensive care: Comparison with measured saturations and transcu-taneous oxygen tension. J Pediatr1985;107:362–366.
220.
DeckardtR, StewardDJ. Noninvasive arterial hemo-globin oxygen saturation versus transcutaneous oxygen tension monitoring in the preterm infant. Crit Care Med1984;12:935–939.
221.
PraudJP, CarofilisA, BrideyF, LacailleF, DehanM, GaultierCL. Accuracy of two wavelength pulse oximetry in neonates and infants. Pediatr Pulmonol1989;6:180–182.
222.
MokJ, PintarM, BensonL, McLaughlinFJ, LevisonH.Evaluation of noninvasive measurements of oxygenation in stable infants. Crit Care Med1986; 14:960–963.
223.
JennisMS, PeabodyJL. Pulse oximetry: An alternative method for the assessment of oxygenation in newborn infants. Pediatrics1987;79:524–528.
224.
WelchJP, DeCesareR, HessD.Pulse oximetry: Instrumentation and clinical applications. Respir Care1990;35:584–601.
225.
ZapolWM, SniderMT, HillD, . Extracorporeal membrane oxygenation in severe acute respiratory failure. JAMA1979;242:2193–2196.
226.
GattinoniL, PresentiA, MascheroniD, . Low-frequency positive-pressure ventilation with extracorpo-real CO₂ removal in severe acute respiratory failure. JAMA1986;256:881–886.
BartlettRH, GazzanigaAB, JefferiesMR. Extracorpo-real membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs1976;22:80–93.
HirschlRB, BartlettRH. Extracorporeal membrane oxygenation support in cardiorespiratory failure. Adv Surg1987;21:189–212.
233.
AndrewsAF, KleinMD, ToomasianJM, RoloffDW, BartlettRH. Venovenous extracorporeal membrane oxygenation in neonates with respiratory failure. J Pediatr Surg1983;18:339–346.
234.
ShortBL, MillerMK, AndersonKD. Extracorporeal membrane oxygenation in the management of respiratory failure in the newborn. Clin Perinatol1987;14:737–748.
235.
RedmondCR, GravesED, FaltermanKW, OchsnerJL, ArensmanRM. Extracorporeal membrane oxygenation for respiratory and cardiac failure in infants and children. J Thorac Cardiovasc Surg1987;93:199–204.
KirkpatrickBV, KrummelTM, MuellerDG, OrmazabalMA, GreenfieldLJ, SalzbergAM. Use of extracorporeal membrane oxygenation for respiratory failure in term infants. Pediatrics1983;72:872–876.
238.
TowneBH, LottIT, HicksDA, HealyT.Long-term follow-up of infants and children treated with extracor-poreal membrane oxygenation (ECMO): A preliminary report. J Pediatr Surg1985;20:410–414.
239.
AndrewsAF, NixonCA, CilleyRE, RoloffDW, BartlettRH. One- to three-year outcome for 14 neonatal survivors of extracorporeal membrane oxygenation. Pediatrics1986;78:692–698.
240.
ToomasianJM, SnedecorSM, CornellRG, CilleyRE, BartlettRH. National experience with extracorporeal membrane oxygenation for newborn respiratory failure: Data from 715 cases. ASAIO Trans1988;34:140–147.
241.
BartlettRH, RoloffDW, CornellRG, AndrewAF, DillonPW, ZwischenbergerJB. Extracorporeal circulation in neonatal respiratory failure: A prospective randomized study. Pediatrics1985;76:479–487.
242.
PanethN, WallensteinS.Extracorporeal membrane oxygenation and the play the winner rule (editorial). Pediatrics1985;76:622–623.
243.
O'RourkePP, CroneRK, VacantiJP, . Extracor-poreal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hyper-tension of the newborn: A prospective randomized trial. Pediatrics1989;84:957–963.
244.
RobillardE, AlarieY, Dagenais-PerusseP, BarilE, GuilbeaultA.Microaerosol administration of synthetic B-gamma-dipalmitoyl-L-a-lecithin in the respiratory distress syndrome. Can Med Assoc J1964;90:55–57.
245.
IkegamiM, HesterbergT, NozakiM, AdamsFH. Restoration of lung pressure-volume characteristics with surfactant: Comparison of nebulization versus instillation and natural versus synthetic surfactant. Pediatr Res1977;11:178–182.
ShapiroDL, NotterRH, MorinFCIII, . Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome. Pediatrics1985;76:593–599.
248.
HallmanM, MerrittTA, JarvenpaaA, . Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective clinical trial. J Pediatr1985;106:963–969.
249.
EnhorningG, ShennanA, PossmayerF, DunnM, ChenCP, MilliganJ.Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant. Pediatrics1985;76:145–153.
250.
WilkinsonA, JenkinsPA, JefferyJA. Two controlled trials of dry artificial surfactant: Early effects and later outcome in babies with surfactant deficiency. Lancet1985;2:287–291.
251.
LangMJ, HallRT, RoddyNS, KurthCG, MerrittTA. A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants. J Pediatr1990;116:295–300.
252.
CouserRJ, FerraraTB, EbertJ, HoekdraRE, FangmanJJ. Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline-membrane disease. J Pediatr1990;116:119–124.
253.
BhatR, DziedzicK, BhutaniV, VidyasagarD.Effect of a single dose surfactant on pulmonary function. Crit Care Med1990;18:590–595.
254.
JobeA, IkegamiM.Surfactant for the treatment of respiratory distress syndrome. Am Rev Respir Dis1987;136:1256–1275.
MerrittTA, HallmanM, SpraggR, HeldtGP, GilliardN.Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome. Drugs1989;38:591–611.
KobayashiT, KahokaH, UedaT, MurakamiS, TakadaY, KokuboM.Effects of surfactant supplement and end-expiratory pressure in lung-lavaged rabbits. J Appl Physiol1984;57:995–1001.
276.
ZelterM, EscudierBJ, HoeffelJM, MurrayJF. Effects of aerosolized artificial surfactant on repeated oleic acid injury in sheep. Am Rev Respir Dis1990;141:1014–1019.
277.
MaunderRJ, HudsonLD. Pharmacologic strategies for treating the adult respiratory distress syndrome. Respir Care1990;35:241–246.
278.
FuhrmanBP. Surfactant therapy: Just for babies? (editorial). Crit Care Med1990;18:682–683.
279.
EnhorningG.Surfactant replacement in adult respiratory distress syndrome (editorial). Am Rev Respir Dis1989;140:281–283.
280.
HolmBA, MatalonS.Role of pulmonary surfactant in the development and treatment of adult respiratory distress syndrome. Anesth Analg1989;69:805–818.
281.
OswaldNC, HaroldJT, MartinWJ. Clinical pattern of chronic bronchitis. Lancet1953;2:639–643.
282.
SametJM, TagerIB, SpeizerFE. The relationship between respiratory illness in childhood and chronic air-flow obstruction in adulthood. Am Rev Respir Dis1983;127:508–523.
283.
MartinezFD, BurrowsB.New perspectives on the relation between respiratory illness in childhood and different forms of chronic airflow limitation in adulthood. Problems Respir Care1990;3:104–118.
284.
BurrowsB, KnudsonRJ, LebowitzMD. The relationship of childhood respiratory illness to adult obstructive airway disease. Am Rev Respir Dis1977;115:751–760.
285.
LebowitzMD, HolbergA, KnudsonRJ, BurrowsB.Longitudinal study of pulmonary function development in childhood, adolescence, and early adulthood. Am Rev Respir Dis1987;136:69–75.
286.
BurrowsB, KnudsonRJ, ClineMG, LebowitzMD. A reexamination of risk factors for ventilatory impairment. Am Rev Respir Dis1988;138:829–836.
287.
WohlMEB, StigolLC, MeadJ.Resistance of the total respiratory system in healthy infants and infants with bronchiolitis. Pediatrics1969;43:495–509.
288.
StokesGM, MilnerAD, HodgesIGC, GrogginsRC. Lung function abnormalities after acute bronchiolitis. J Pediatr1981;98:871–874.
289.
KattanM, KeensTG, LapierreJ, LevisonH, BryanC, ReillyBJ. Pulmonary function abnormalities in symptom-free children after bronchiolitis. Pediatrics1977;59:683–688.
290.
SimsDG, DownhamMAPS, GardnerPS, WebbJKG, WeightmanD.Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy. Br Med J1978;1:11–14.
291.
GurwitzD, MindorffC, LevisonH.Increased incidence of bronchial reactivity in children with a history of bronchiolitis. J Pediatr1981;98:551–555.
292.
PullanCR, HeyEN. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br Med J1982;284:1665–1669.
WeissST, TagerIB, MunozA, SpeizerFE. The relationship of respiratory infections in early childhood.
298.
VoterKZ, HenryMM, StewartPW, HendersonFW. Lower respiratory illness in early childhood and lung function and bronchial reactivity in adolescent males. Am Rev Respir Dis1988;137:302–307.
299.
GoldDR, TagerIB, WeissST, TostesonTD, SpeizerFE. Acute lower respiratory illness in childhood as a predictor of lung function and chronic respiratory symptoms. Am Rev Respir Dis1989;140:877–884.
300.
TagerIB. Health effects of "passive smoking" in children. Chest1989;96:1161–1164.
301.
SchenkerMB, PocekayDE. Environmental tobacco smoke: Assessment of exposure and effects on respiratory health. Problems Respir Care1990;3:193–205.
302.
HarlapS, DaviesAM. Infant admissions to hospital and maternal smoking. Lancet1974;1:529–534.
303.
BlandM, BewleyBR, PollardV, BanksMH. Effect of children's and parents' smoking on respiratory symptoms. Arch Dis Child1978;53:100–105.
304.
WeissST, TagerIB, SpeizerFE, RosnerB.Persistent wheeze. Am Rev Respir Dis1980;122:697–707.
305.
LebowitzMD, HolbergCJ. Effects of parental smoking and other risk factors on the development of pulmonary function in children and adolescents. Am J Epidemiol1988;128:589–597.
306.
TagerIB. "Passive smoking" and respiratory health in children—Sophistry or cause for concern? (editorial). Am Rev Respir Dis1986;133:959–961.
307.
MasiMA, HanleyJA, ErnstP, BecklakeMR. Environmental exposure to tobacco smoke and lung function in young adults. Am Rev Respir Dis1988;138:296–299.
308.
TagerIB, WeissST, RosnerB, SpeizerFE. Effect of parental cigarette smoking on the pulmonary function of children. Am J Epidemiol1979;110:15–26.
309.
WoolcockAJ, LeederSR, PeatJK, BlackburnCRB. The influence of lower respiratory illness in infancy and childhood and subsequent cigarette smoking on lung function in Sydney schoolchildren. Am Rev Respir Dis1979;120:5–14.
310.
KoffPB. Perinatal/pediatric specialty examination: Personnel survey summary and plans for job analysis. NBRC Newsletter1988;14(5):1,4.
